A Multispecific Checkpoint Inhibitor Nanofitin with a Fast Tumor Accumulation Property and Anti-Tumor Activity in Immune Competent Mice

Immune checkpoint inhibitors have revolutionized cancer treatment but remain limited by on-target/off-tumor effects that narrow their therapeutic window. Although PD-L1 is mainly expressed by tumor cells, these effects could reduce bloodstream availability and tumor accumulation of PD-L1 inhibitors....

Popoln opis

Bibliografske podrobnosti

Principais autores:	Perrine Jacquot, Javier Muñoz-Garcia, Antoine Léger, Antoine Babuty, Manon Taupin, Laurie Fradet, Fabio Dupont, Marie-Françoise Heymann, Mathieu Cinier, Dominique Heymann
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2025-03-01
Serija:	Biomolecules
Teme:	bispecific Nanofitin programmed cell death-ligand 1 (PD-L1) epidermal growth factor receptor (EGFR) on-target/off-tumor effect tumoral accumulation
Online dostop:	https://www.mdpi.com/2218-273X/15/4/471
Oznake:	Označite Brez oznak, prvi označite!